Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

CVT-313, a specific and potent inhibitor of CDK2 that prevents neointimal proliferation.

CVT-313, a specific and potent inhibitor of CDK2 that prevents neointimal proliferation. J Biol Chem. 1997 Nov 14; 272(46):29207-11.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.